Celera (NASDAQ:CRA) today announced the appointment of K. Scott Bland to the new position of Vice President of Sales at its Berkeley HeartLab, or BHL, subsidiary. The appointment is effective immediately and Mr. Bland will report to Chris Hall, Chief Business Officer of BHL. Mr. Bland has been a regional director of sales at BHL, […]
Sequenom, Inc. (NASDAQ:SQNM) announced that it intends to make an exchange offer to acquire all of the outstanding shares of common stock of EXACT Sciences Corporation (NASDAQ:EXAS) in an all-stock transaction valued at approximately $41 million. Under the terms of the proposal, each share of EXACT Sciences would be exchanged for $1.50 in Sequenom common […]
Perlegen, a leader in correlating genetic variation to predisposition to disease and drug response through development of genetic tests, announced today that it has hired Mark J. Ostrowski as senior vice president of sales. In this newly created position, Mr. Ostrowski will bring his deep experience with Perlegen’s commercial targets to reach and expand the […]
Clarient, Inc. (Nasdaq: CLRT), a premier anatomic pathology and molecular testing services resource for pathologists, oncologists, and the pharmaceutical industry, today announced the commercial launch of its new gene expression test for prostate cancer. This new test will be available through Clarient’s PATHSiTETM virtual reporting tool and accessible to the company’s entire pathology network Clarient’s […]
Novel Technology Designed to Optimize Early Detection of Potentially Fatal Immune System Dysfunction in Infants SAN FRANCISCO & SAN DIEGO–The Immune Tolerance Institute, Inc. (ITI), and Sequenom, Inc. (NASDAQ: SQNM), today announced a collaboration to develop an advanced newborn screening test for severe combined immunodeficiency (SCID) based on the pioneering work of Jennifer Puck, MD, […]
New Version Increases Physician Access SUNNYVALE, Calif., Jan. 13 — Pathwork Diagnostics, Inc., launched today an additional version of the Pathwork(R) Tissue of Origin Test that has the capability of analyzing formalin-fixed, paraffin-embedded (FFPE) tissue specimens. This molecular diagnostic test, which aids in the diagnosis of tumors with uncertain origins, is now available as a […]
Invitrogen, a division of Life Technologies Corporation (NASDAQ:LIFE), today announced that its DynaChip® HLA Antibody Analysis System has received approval from Health Canada’s Medical Device Bureau for the detection and identification of antibodies to human leukocyte antigen (HLA) markers, which is an essential step in determining the compatibility of organ donors. HLA markers are proteins […]
Evogen, Inc., a global molecular diagnostics company, and LGC, an international science-based company and recognised provider of laboratory services and measurement standards, announced today that they have signed a worldwide license agreement of LGC’s HyBeacons® PCR probe chemistry technology to Evogen to augment the recently launched rapid molecular diagnostics and detection platform, including the flagship […]
VENLO, THE NETHERLANDS–Jan 12, 2009 — QIAGEN led-consortium to develop standards for patient sample processing in order to facilitate the discovery and prediction of diseases Venlo, The Netherlands, January 12, 2009 – The European Union launched a new research project targeting to expand the potentials and utility of in-vitro diagnostics through the creation of new […]
Expands BD GeneOhm(TM) Assay Menu to Detect Major Healthcare-Associated Infections (HAIs) SAN DIEGO, Jan. 12 — BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX) , announced today it has received clearance from the U.S. Food and Drug Administration to market the BD GeneOhm(TM) Cdiff molecular assay for the rapid detection of […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
